Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Finasteride may increase suicide risk; more research needed.

Noninvasive treatments like PRP and laser therapy can effectively promote hair growth and reduce hair loss.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

The nutritional supplement improved hair quality and reduced hair loss.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Finasteride might affect memory by impacting cholinergic system.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

Finasteride may affect PNMT, causing side effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

New treatments and diagnostic methods for various animal skin conditions showed promising results.